Patient self-appraisal of change and minimal clinically important difference on the European organization for the research and treatment of cancer quality of life questionnaire core 30 before and during cancer therapy

Table 1 Demographic and clinical characteristics of 627 medical/radiation (MED/RAD) oncology and transplant (SCT) patients

	Clinical service
	SCT( n = 191)		MED/RAD (n = 436)
	N	%	N	%
Sex, Male	111	58.1	229	52.5
Age, years	49 (12.9)		56 (13.9)
Mean (SD)	49 (12.9)		56 (13.9)
Range	19-75		18-89
Ethnicity, Hispanic/Latino	2	1.0	9	2.1
Race, minority or multiple	13	6.8	32	7.3
Some college or college graduate	146	76.4	299	68.6
Married/Partnered	138	72.3	303	69.5
Low annual household income (<=$35,000)	44	23.0	101	23.2
Study Group (Intervention)*	92	48.2	217	49.8
Incident cancer diagnosis	134	70.2	370	84.9
Cancer type	0	0	42	9.6
Breast	0	0	42	9.6
GI	0	0	80	18.3
GU	0	0	70	16.1
Gyn	0	0	49	11.2
Head and Neck	0	0	53	12.2
Leukemia	88	46.1	6	1.4
Lung	0	0	41	9.4
Lymphoma	62	32.5	40	9.2
Myeloma	38	19.9	7	1.6
Other	3	1.5	48	11.0
Days between T1 and T2, days
Median, range	42 (14–107)		41(11–105)

*In the intervention group, Patient-reported quality-of-life issues were automatically displayed on a graphical summary and provided to the clinical team before an on-treatment visit; in the control group, no summary was provided. Details on study design can be found in Berry et al. [16].

ISSN: 1471-2407